id: NEW:oliceridine_biased_opioid_agonism_to_NEW:postoperative_pain_management_efficacy
name: Oliceridine Biased Opioid Agonism â†’ Postoperative Pain Management Efficacy
from_node:
  node_id: NEW:oliceridine_biased_opioid_agonism
  node_name: Oliceridine Biased Opioid Agonism
to_node:
  node_id: NEW:postoperative_pain_management_efficacy
  node_name: Postoperative Pain Management Efficacy
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Oliceridine acts as a biased agonist at mu-opioid receptors, preferentially activating G-protein
  signaling over beta-arrestin pathways'
- 'Step 2: This biased agonism provides analgesic effects comparable to conventional opioids for acute
  postoperative pain'
- 'Step 3: Effective pain control is achieved within 72 hours post-surgery through intravenous administration'
evidence:
  quality_rating: C
  n_studies: 0
  primary_citation: Anne Wolf et al. 2024. "Efficacy, safety, and side effects of oliceridine in acute
    postoperative pain, a protocol for a systematic review and meta-analysis." https://doi.org/10.1371/journal.pone.0299320
  supporting_citations:
  - Additional citations require full-text access - this is a protocol paper describing planned methodology
  - Protocol references randomized controlled trials to be identified through systematic database search
  - Studies comparing oliceridine to placebo or morphine will be included
  doi: 10.1371/journal.pone.0299320
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: This systematic review protocol aims to evaluate whether oliceridine, a novel biased opioid
  agonist, provides effective pain management for acute postoperative pain compared to placebo or morphine.
  The planned meta-analysis will synthesize evidence from RCTs examining efficacy within 72 hours post-surgery.
moderators:
- name: dose
  direction: strengthens
  strength: moderate
  description: Meta-regression planned to evaluate dose-dependent effects on both efficacy and side effects
structural_competency:
  equity_implications: This mechanism relates to healthcare system access to newer pharmacological options
    for pain management. The availability of alternative opioids with potentially fewer side effects could
    have implications for reducing opioid-related harms at population level. However, access to such medications
    may vary by insurance status, hospital formulary decisions, and healthcare system resources, potentially
    creating disparities in pain management quality.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:38.109216'
  extraction_confidence: low
  prompt_version: 2.1-canonical-validated
